Aethlon Medical shareholders approve 3M share increase to 2020 Equity Plan; all director nominees elected

AETHLON MEDICAL INC

Shareholders approved amendment to 2020 Equity Incentive Plan, increasing authorized shares by 3,000,000 to total 3,364,256 shares.
Five directors elected: Broenniman, Frakes, Gikakis, Rossetti, Shah, each with over 2.9M votes for.
Ratification of Haskell & White LLP as independent auditor approved: 4.70M for, 163,731 against.
Non-binding advisory vote on executive compensation approved: 2.76M for, 245,575 against.
Plan amendment effective September 27, 2024, after receiving stockholder approval.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.